ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $6.69M invested in Entero Therapeutics in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$280K
2
+$182K
3
+$169K

Top Sellers

1
-$159K
2
-$73K
3
-$45K
4
BlackRock
BlackRock
New York
-$34K
5
BFM
Boothbay Fund Management
New York
-$28K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.68M
2
$1.4M
3
$1.31M
4
$1.04M
5
$363K
6
$182K
7
$177K
8
$169K
9
$145K
10
$65K
11
$55K
12
$48K
13
$29K
14
$8K
15
$4K
16
$3K
17
–
18
–
19
–
20
–